mGluR5 receptor availability is associated with lower levels of negative symptoms and better cognition in male patients with chronic schizophrenia

Consistent findings postulate disturbed glutamatergic function (more specifically a hypofunction of the ionotropic NMDA receptors) as an important pathophysiologic mechanism in schizophrenia. However, the role of the metabotropic glutamatergic receptors type 5 (mGluR5) in this disease remains unclea...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Hum Brain Mapp
Päätekijät: Régio Brambilla, Cláudia, Veselinović, Tanja, Rajkumar, Ravichandran, Mauler, Jörg, Orth, Linda, Ruch, Andrej, Ramkiran, Shukti, Heekeren, Karsten, Kawohl, Wolfram, Wyss, Christine, Kops, Elena Rota, Scheins, Jürgen, Tellmann, Lutz, Boers, Frank, Neumaier, Bernd, Ermert, Johannes, Herzog, Hans, Langen, Karl‐Josef, Jon Shah, N., Lerche, Christoph, Neuner, Irene
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley & Sons, Inc. 2020
Aiheet:
Research Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7294054/
https://ncbi.nlm.nih.gov/pubmed/32150317
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hbm.24976
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia